Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

Published:2017-06-18 Issue:5 Volume:12 Page:563-569
ISSN:1776-2596
Container-title:Targeted Oncology
language:en
Short-container-title:Targ Oncol

Author:

Bylicki Olivier^ORCID,Paleiron Nicolas,Margery Jacques,Guisier Florian,Vergnenegre Alain,Robinet Gilles,Auliac Jean-Bernard,Gervais Radj,Chouaid Christos

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s11523-017-0510-9/fulltext.html

Reference63 articles.

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.

2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.

4. Gridelli C, Besse B, Brahmer JR, Crinò L, Felip E, de Marinis F. The evolving role of nivolumab in non-small-cell lung cancer for second-line treatment: a new cornerstone for our treatment algorithms. Results from an international experts panel meeting of the Italian Association of Thoracic Oncology. Clin Lung Cancer. 2016;17(3):161–8.

5. Kazandjian D, Suzman DL, Blumenthal G, Mushti S, He K, Libeg M, et al. FDA approval summary: nivolumab for the treatment of metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy. Oncologist. 2016;21(5):634–42.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory parameters in NSCLC with driver mutation;Lung Cancer Management;2024-02-28

2. Co-delivery of PD-L1- and EGFR-targeting siRNAs by synthetic PEG12-KL4 peptide to the lungs as potential strategy against non-small cell lung cancer;European Journal of Pharmaceutics and Biopharmaceutics;2024-02

3. Identification of potential biomarkers and infiltrating immune cells from scalp psoriasis;Gene;2024-01

4. The new idea of cancer immunotherapy: the expression of PD-L1 may reveal the immunological mechanism of resistance of EGFR-TKIs;2023-12-06

5. TCM monotherapy achieves significant efficacy in crizotinib-refractory advanced NSCLC with brain metastasis;Medicine;2023-07-21